Olema Pharmaceuticals OLMA
NASDAQ OLMA
$7.16 -0.11 (-1.51%)
As of: Nov 11, 2026 · 10:46 AM EST

Olema Pharmaceuticals (OLMA) Accumulated Expenses (2022 - 2023)

Updated

Olema Pharmaceuticals' Accumulated Expenses was $12.84 million in Q3 2023, up 3.4% from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Accumulated Expenses (2022 - 2023) Analysis & Trends

At the end of FY2022, Accumulated Expenses at Olema Pharmaceuticals came in at $15.16 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Olema Pharmaceuticals 734.94 Mn -1.15 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 12.84 Mn
Jun 30, 2023 12.41 Mn
Dec 31, 2022 15.16 Mn
API Access

Olema Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=OLMA&period=max&api_key=YOUR_API_KEY